Scientific Publication:

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models

Authors: 
Ku Min-Wen, Bourgine Maryline, Authié Pierre, Lopez Jodie, Nemirov Kirill, Moncoq Fanny, Noirat Amandine, Vesin Benjamin, Nevo Fabien, Blanc Catherine, Souque Philippe, Tabbal Houda, Simon Emeline, Hardy David, Le Dudal Marine, Guinet Françoise, Fiette Laurence, Mouquet Hugo, Anna François, Martin Annette, Escriou Nicolas, Majlessi Laleh, Charneau Pierre
Journal: 
Cell Host & Microbe
Date of publication: 
Monday, 1 February, 2021
Volume: 
29
Issue: 
2
Pages: 
236-249.e6
Related PMID: 
33357418
Related DOI: 
10.1016/j.chom.2020.12.010
EVAg connections: 
Research funded by EVAg
Related to EVAg product
Published by EVAg partner
This publication has been related to the following 1 product(s) of our catalogue

1 products displayed

SARS-CoV-2 isolate - BetaCoV/France/ IDF0372/2020

REFERENCE STRAIN
Produced by:
IP
Shipping From:
Paris - FR
virus
Ref-SKU:
014V-03890
Infectious cell culture supernatant containing BetaCoV/France/IDF0372/2020, clade 19A
Unit: one vial
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus / Sarbecovirus / Severe acute respiratory syndrome-related coronavirus
Virus name: 
SARS-CoV-2
Genotype: 
clade 19A


2 000,00 €
 (Cost per access for Academics)

View details...